JPWO2020263187A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020263187A5
JPWO2020263187A5 JP2021577361A JP2021577361A JPWO2020263187A5 JP WO2020263187 A5 JPWO2020263187 A5 JP WO2020263187A5 JP 2021577361 A JP2021577361 A JP 2021577361A JP 2021577361 A JP2021577361 A JP 2021577361A JP WO2020263187 A5 JPWO2020263187 A5 JP WO2020263187A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
independently
groups
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542645A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2020/050363 external-priority patent/WO2020263187A1/en
Publication of JP2022542645A publication Critical patent/JP2022542645A/ja
Publication of JPWO2020263187A5 publication Critical patent/JPWO2020263187A5/ja
Pending legal-status Critical Current

Links

JP2021577361A 2019-06-25 2020-06-25 眼障害の治療のための化合物 Pending JP2022542645A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201905890P 2019-06-25
SG10201905890P 2019-06-25
PCT/SG2020/050363 WO2020263187A1 (en) 2019-06-25 2020-06-25 Compounds for treatment of eye disorders

Publications (2)

Publication Number Publication Date
JP2022542645A JP2022542645A (ja) 2022-10-06
JPWO2020263187A5 true JPWO2020263187A5 (es) 2023-05-24

Family

ID=74062096

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577346A Pending JP2022543343A (ja) 2019-06-25 2020-06-25 がんの治療のための化合物
JP2021577361A Pending JP2022542645A (ja) 2019-06-25 2020-06-25 眼障害の治療のための化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021577346A Pending JP2022543343A (ja) 2019-06-25 2020-06-25 がんの治療のための化合物

Country Status (11)

Country Link
US (2) US20220242863A1 (es)
EP (2) EP3990458A1 (es)
JP (2) JP2022543343A (es)
KR (1) KR20220054286A (es)
CN (2) CN114450285B (es)
AU (2) AU2020301057A1 (es)
BR (1) BR112021026366A2 (es)
CA (2) CA3144226A1 (es)
IL (2) IL289221A (es)
MX (2) MX2022000099A (es)
WO (2) WO2020263187A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113354576B (zh) * 2021-06-28 2022-08-12 黑龙江立科新材料有限公司 邻位烷氧基取代的吡啶类化合物的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
EP1773826A4 (en) * 2004-07-02 2009-06-03 Exelixis Inc MODULATORS OF C-MET AND THEIR METHOD OF USE
DOP2006000051A (es) * 2005-02-24 2006-08-31 Lilly Co Eli Inhibidores de vegf-r2 y métodos
GB0507575D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
KR100787131B1 (ko) * 2006-07-04 2007-12-21 한국생명공학연구원 Ｈｉｆ―１ 활성을 저해하는 화합물, 이의 제조방법 및이를 유효성분으로 함유하는 약학적 조성물
CN101558068A (zh) * 2006-10-16 2009-10-14 诺瓦提斯公司 用作蛋白激酶抑制剂的苯乙酰胺类
WO2008112695A2 (en) * 2007-03-12 2008-09-18 Irm Llc Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment
EP2903645A2 (en) * 2012-10-05 2015-08-12 Kadmon Corporation, LLC Treatment of ocular disorders
GB2508652A (en) * 2012-12-07 2014-06-11 Agency Science Tech & Res Heterocyclic piperazine derivatives
WO2015031613A1 (en) * 2013-08-30 2015-03-05 Ambit Biosciences Corporation Biaryl acetamide compounds and methods of use thereof
WO2015043492A1 (en) * 2013-09-26 2015-04-02 Sunshine Lake Pharma Co., Ltd. Substituted urea derivatives and uses thereof in medicine
CN105294680A (zh) * 2014-06-25 2016-02-03 中国药科大学 Vegfr-2不可逆抑制剂及其用途
WO2016004254A1 (en) * 2014-07-01 2016-01-07 The Regents Of The University Of California Combined modulation of ire1
CN104876912B (zh) * 2015-04-08 2017-07-21 苏州云轩医药科技有限公司 Wnt信号通路抑制剂及其应用
KR102128018B1 (ko) * 2017-05-12 2020-06-30 한국화학연구원 피라졸로 피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암, 자가면역질환 및 뇌질환의 예방 또는 치료용 약학적 조성물
SG11202005278PA (en) * 2017-12-29 2020-07-29 Agency Science Tech & Res Compounds for treating eye diseases and methods thereof

Similar Documents

Publication Publication Date Title
JP2023052069A5 (es)
JP2010513322A5 (es)
CN1131217C (zh) 苯基吡咯化合物和其制备方法及抗高血脂药
JP5094721B2 (ja) Ｎ−フェニル−２−ピリミジン−アミン誘導体及びそれの調製のための工程
JP2018536648A5 (es)
JP2007519695A5 (es)
JP2017504595A5 (es)
HRP20120990T1 (hr) Postupak sinteze spojeva korisnih za lijeäśenje hepatitisa c
JP2017502006A5 (es)
AR064197A1 (es) Derivados de pirimidina y piridina inhibidores de la proteina quinasa
JP2016515096A (ja) スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用
WO2008009078A3 (en) 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
JP2010513319A5 (es)
DE69914931D1 (de) 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung
JP2006522827A5 (es)
US20030009034A1 (en) Transition metal mediated process
JPWO2021245051A5 (es)
JPWO2020263187A5 (es)
JPWO2020106816A5 (es)
JP2006519216A5 (es)
JP2005511535A5 (es)
JP2008538113A5 (es)
JP2016526563A5 (es)
AR076014A1 (es) Derivados de 3- (1,4) oxazepan -4-pirimidona
JP6484168B2 (ja) 抗ウイルス活性を有するメタンチオン化合物